403
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Genome-Wide Methylation and Expression Profiling Identify Methylation-Associated Genes in Colorectal Cancer

, , , , , , & show all
Pages 19-36 | Received 13 May 2019, Accepted 31 Oct 2019, Published online: 13 Dec 2019

References

  • Ferlay J , SoerjomataramI , DikshitRet al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer136(5), E359–E386 (2015).
  • Siegel RL , MillerKD , JemalA. Cancer Statistics, 2017. CA Cancer J. Clin.67(1), 7–30 (2017).
  • Siegel RL , MillerKD , FedewaSAet al. Colorectal cancer statistics, 2017. CA Cancer J. Clin.67(3), 177–193 (2017).
  • Migheli F , MiglioreL. Epigenetics of colorectal cancer. Clin. Genet.81(4), 312–318 (2012).
  • Egger G , LiangG , AparicioA , JonesPA. Epigenetics in human disease and prospects for epigenetic therapy. Nature429(6990), 457–463 (2004).
  • Jones PA . DNA methylation and cancer. Cancer Res.46(2), 461–466 (1986).
  • Baylin SB , HermanJG. DNA hypermethylation in tumorigenesis – epigenetics joins genetics. Trends Genet.16(4), 168–174 (2000).
  • Esteller M , CornPG , BaylinSB , HermanJG. A gene hypermethylation profile of human cancer. Cancer Res.61(8), 3225–3229 (2001).
  • Okugawa Y , GradyWM , GoelA. Epigenetic alterations in colorectal cancer: emerging biomarkers. Gastroenterology149(5), 1204-1225 (2015).
  • Tang QQ , ChengJ , CaoX , SurowyH , BurwinkelB. Blood-based DNA methylation as biomarker for breast cancer: a systematic review. Clin. Epigenetics8(1), 115 (2016).
  • Weisenberger DJ , LiangG , LenzHJ. DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies. Oncogene37(5), 566–577 (2018).
  • Galanopoulos M , TsoukalasN , PapanikolaouIS , ToliaM , GazouliM , MantzarisGJ. Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: a review of literature. World. J. Gastrointest. Oncol.9(4), 142–152 (2017).
  • Lyberopoulou A , GalanopoulosM , AravantinosGet al. Identification of methylation profiles of cancer-related genes in circulating tumor cells population. Anticancer Res.37(3), 1105–1112 (2017).
  • Mcinnes T , ZouD , RaoDSet al. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer. BMC Cancer17(1), 228 (2017).
  • Naumov VA , GenerozovEV , ZaharjevskayaNBet al. Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics8(9), 921–934 (2013).
  • Kordowski F , KolarovaJ , SchafmayerCet al. Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers. BMC Cancer18(1), 796 (2018).
  • Fadda A , GentiliniD , MoiLet al. Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor. Int. J. Cancer143(4), 907–920 (2018).
  • Zhu YM , LuHL , ZhangDDet al. Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer. Clin. Epigenetics10(1), 30 (2018).
  • Audic S , ClaverieJM. The significance of digital gene expression profiles. Genome Rres.7(10), 986–995 (1997).
  • Li M , WuH , LuoZet al. An atlas of DNA methylomes in porcine adipose and muscle tissues. Nat. Commun.3, 850 (2012).
  • Ashktorab H , DaremipouranM , GoelAet al. DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia. Epigenetics9(4), 503–512 (2014).
  • Wilmot B , FryR , SmeesterL , MusserED , MillJ , NiggJT. Methylomic analysis of salivary DNA in childhood ADHD identifies altered DNA methylation in VIPR2. J. Child Psychol. Psychiatry57(2), 152–160 (2016).
  • Sun X , TianY , ZhengQet al. A novel discriminating colorectal cancer model for differentiating normal and tumor tissues. Epigenomics10(11), 1463–1475 (2018).
  • Michailidi C , TheocharisS , TsourouflisGet al. Expression and promoter methylation status of hMLH1, MGMT, APC, and CDH1 genes in patients with colon adenocarcinoma. Exp. Biol. Med.240(12), 1599–1605 (2015).
  • Baylin SB , JonesPA. A decade of exploring the cancer epigenome – biological and translational implications. Nat. Rev. Cancer11(10), 726–734 (2011).
  • Kim MS , LeeJ , SidranskyD. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev.29(1), 181–206 (2010).
  • Lao VV , GradyWM. Epigenetics and colorectal cancer. Nat. Rev. Gastroenterol. Hepatol.8(12), 686–700 (2011).
  • Qasim BJ , Al-WasitiEA , AzzalHS. Association of global DNA hypomethylation with clinicopathological variables in colonic tumors of Iraqi patients. Saudi J. Gastroenterol.22(2), 139–147 (2016).
  • Matsubara N . Epigenetic regulation and colorectal cancer. Dis. Colon Rectum55(1), 96–104 (2012).
  • Schuebel KE , ChenW , CopeLet al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet.3(9), 1709–1723 (2007).
  • Jung M , KristiansenG , DietrichD. DNA methylation analysis of free-circulating DNA in body fluids. Methods Mol. Biol.1708, 621–641 (2018).
  • Schubeler D . Function and information content of DNA methylation. Nature517(7534), 321–326 (2015).
  • Guo S , DiepD , PlongthongkumN , FungHL , ZhangK , ZhangK. Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA. Nat. Genet.49(4), 635 (2017).
  • Shoemaker R , DengJ , WangW , ZhangK. Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome. Genome Res.20(7), 883–889 (2010).
  • Jones B . DNA METHYLATION Switching phenotypes with epialleles. Nat. Rev. Genet.15(9), 572 (2014).
  • Saito D , SuyamaM. Linkage disequilibrium analysis of allelic heterogeneity in DNA methylation. Epigenetics10(12), 1093–1098 (2015).
  • Wei J , LiG , ZhangJet al. Integrated analysis of genome-wide DNA methylation and gene expression profiles identifies potential novel biomarkers of rectal cancer. Oncotarget7(38), 62547–62558 (2016).
  • Bhattacharjee P , PaulS , BanerjeeMet al. Functional compensation of glutathione S-transferase M1 (GSTM1) null by another GST superfamily member, GSTM2. Sci. Rep.3, 2704 (2013).
  • Han I , JeongSJ , LeeHJet al. Proteomic analysis of mesenchymal stem-like cells derived from ovarian teratoma: potential role of glutathione S-transferase M2 in ovarian teratoma. Proteomics11(3), 352–360 (2011).
  • Weng MW , HsiaoYM , ChiouHLet al. Alleviation of benzo[a]pyrene-diolepoxide-DNA damage in human lung carcinoma by glutathione S-transferase M2. DNA Repair4(4), 493–502 (2005).
  • Tang SC , SheuGT , WongRHet al. Expression of glutathione S-transferase M2 in stage I/II non-small cell lung cancer and alleviation of DNA damage exposure to benzo[a]pyrene. Toxicol. Lett.192(3), 316–323 (2010).
  • Huang Q , YangQ , MoMet al. Screening of exon methylation biomarkers for colorectal cancer via LC-MS/MS strategy. J. Mass Spectrom.52(12), 860–866 (2017).
  • Oster B , ThorsenK , LamyPet al. Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. Int. J. Cancer129(12), 2855–2866 (2011).
  • Lind GE , DanielsenSA , AhlquistTet al. Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas. Mol. Cancer10, 85 (2011).
  • Raveh S , GavertN , SpiegelI , Ben-Ze’evA. The cell adhesion nectin-like molecules (Necl) 1 and 4 suppress the growth and tumorigenic ability of colon cancer cells. J. Cell. Biochem.108(1), 326–336 (2009).
  • Jantscheff P , TerraccianoL , LowyAet al. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J. Clin. Oncol.21(19), 3638–3646 (2003).
  • Liu YY , XiaTT , JinCHet al. FOXP3 and CEACAM6 expression and T cell infiltration in the occurrence and development of colon cancer. Oncol. Lett.11(6), 3693–3701 (2016).
  • Kim KS , KimJT , LeeSJet al. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer. Clin. Chim. Acta415, 12–19 (2013).
  • Lan T , ChenY , SangJet al. Type II cGMP-dependent protein kinase inhibits EGF-induced MAPK/JNK signal transduction in breast cancer cells. Oncol. Rep.27(6), 2039–2044 (2012).
  • Cook AL , HaynesJM. Protein kinase G II-mediated proliferative effects in human cultured prostatic stromal cells. Cell. Signal.16(2), 253–261 (2004).
  • Wang R , KwonIK , ThangarajuMet al. Type 2 cGMP-dependent protein kinase regulates proliferation and differentiation in the colonic mucosa. Am. J. Physiol. Gastrointest. Liver Physiol.303(2), G209–G219 (2012).
  • Wu CJ , QiuSQ , LuLTet al. RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer. Nat. Commun.5, 3149 (2014).
  • Dong XM , LiaoWQ , ZhangLet al. RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway. Cancer Lett.402, 153–165 (2017).
  • Yan W , WangWL , ZhuF , ChenSQ , LiQL , WangL. Isolation of a novel member of small G protein superfamily and its expression in colon cancer. World J. Gastroenterol.9(8), 1719–1724 (2003).
  • Ma Q , WuXX , WuJ , LiangZY , LiuTH. SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-kappa B axis. Int. J. Oncol.51(4), 1104–1114 (2017).
  • Cieply B , RileyPT , PiferPMet al. Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2. Cancer Res.72(9), 2440–2453 (2012).
  • Xiang JF , FuX , RanWHet al. Expression and role of grainyhead-like 2 in gastric cancer. Med. Oncol.30(4), 714 (2013).
  • Quan YJ , XuM , CuiP , YeM , ZhuangB , MinZJ. Grainyhead-like 2 promotes tumor growth and is associated with poor prognosis in colorectal cancer. J. Cancer6(4), 342–350 (2015).
  • Quan YJ , JinRS , HuangAet al. Downregulation of GRHL2 inhibits the proliferation of colorectal cancer cells by targeting ZEB1. Cancer Biol. Ther.15(7), 878–887 (2014).
  • Kostareli E , HolzingerD , BogatyrovaOet al. HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas. J. Clin. Invest.123(6), 2488–2501 (2013).
  • Bennett LB , SchnabelJL , KelchenJMet al. DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma. Genes Chromosomes Cancer48(9), 828–841 (2009).
  • Lind GE , KleiviK , MelingGIet al. ADAMTS1, CRABP1 and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. Cell. Oncol.28(5–6), 259–272 (2006).
  • Pawlak A , ZioloE , FiedorowiczA , FidytK , StrzadalaL , KalasW. Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5-azanucleosides and topoisomerase inhibitors. BMC Cancer16(1), 893 (2016).
  • Bhat AA , WaniHA , IshaqSet al. Promoter hypermethylation and its impact on expression of MGMT gene in the GIT malignant patients of Kashmiri origin. Cancer Invest.35(2), 116–121 (2017).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.